- £13.20bn
- £3.54bn
- £20.15bn
- 34
- 88
- 95
- 87
R2019 December 31st | C2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 66,223 | 30,339 | 32,638 | 14,382 | 20,145 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 62,307 | 28,444 | 31,761 | 16,520 | 18,352 |
Operating Profit | 3,916 | 1,895 | 877 | -2,138 | 1,793 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,821 | 1,812 | 801 | -2,239 | 1,690 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,620 | 1,466 | 336 | -1,030 | 1,106 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,548 | 2,798 | 1,966 | -1,051 | 1,085 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2,497 | 2,754 | 1,948 | -1,085 | 1,034 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.834 | 0.472 | 0.082 | -0.346 | 0.378 |
Dividends per Share |